Cannabis Law Report

NOVEMBER 26, 2019

Among Canadians who report using cannabis as a medical remedy treatment or therapy, the top ailments they use cannabis for are stress/anxiety (63%), pain management (56%), chronic pain including arthritis (44%), and weight management (32%). We are partnering with Canopy Growth to offer a unique event of fun and canna-learning.

Chronic Pain 91

Chronic Pain Events THC Education 91

Project CBD

DECEMBER 31, 2022

Adverse events related to cannabis use were predominately mild or moderate, with insomnia and fatigue being most common at 20 incidents each. The authors’ analysis also revealed that those who used products with higher CBD concentrations (primarily smoked flower, but not exclusively) reported fewer early awakenings, and thus longer sleep.

Sleep 130

Sleep Patients Treatment Cannabis 130

The Cannigma

JULY 17, 2022

You don’t need a medical condition or a paid subscription – the ROC serves curious consumers, medical professionals, and anyone else who is looking to better their life through cannabinoid therapies. To support their efforts in providing free cannabis education, the ROC hosts fundraisers and advocacy events to raise money.

Advocacy 135

Advocacy Education Events Epilepsy 135

Miss Marijuana

JUNE 15, 2019

A new study finds that CBD for PTSD symptoms can be effective. . PTSD is recognized as a Trauma and Stressor-related Disorder in the DSM-5 , and develops through a severely distressing mental and/or physical event, like a terrorist attack, military combat, serious accidents or sexual violence. By: Madeleine Balestrier. million people.

CBD 75

CBD Research and Development Oil Treatment 75

Veriheal

APRIL 18, 2024

CBD (cannabidiol) has been demonstrated to be effective at treating a wide range of mental and physical health disorders, from chronic pain to inflammation, anxiety, insomnia, and much more. Their results were promising, as they found that CBD resulted in better treatment outcomes and fewer side effects than traditional medications.

Treatment 59

Treatment CBD Chronic Pain Events 59

The Joint Blog

DECEMBER 23, 2019

The topical use of cannabidiol (CBD), a nonpsychoactive component of marijuana, is associated with significantly reduced pain in patients with peripheral neuropathy. For the study researchers examined the effects of topical CBD oil l in the management of neuropathic pain. No adverse events were reported in this study.

Topical 49

Topical CBD Therapy Treatment 49

NORML

MARCH 1, 2019

Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. House Bill 19-1028 would permit physicians to recommend cannabis therapy to those diagnosed with an autism spectrum disorder. Click here to email your lawmakers in support of medical expansion.

Legislation 185

Legislation Compliance Compliance Hemp 185

MMJ Recs

JULY 11, 2024

It is often caused by life events such as stress, anxiety, or a significant change in routine. Each type of insomnia may require different treatment approaches, including behavioral therapy, medication, lifestyle changes, or addressing underlying medical or psychological issues.

Sleep 111

Sleep Treatment Research and Development Therapy 111

NORML

FEBRUARY 1, 2019

And officials in San Francisco, California are considering a proposal to allow marijuana to be socially consumed and sold at temporary events. Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. grams of marijuana. IA resident? OR resident?

Legislation 177

Legislation Decriminalization Access Patients 177

The Joint Blog

APRIL 17, 2020

This study summarizes potential adverse drug events related to THC when combined with other medications Medicinal Use of Marijuana Cannabis has been used widely across North America in various state or provincial medical marijuana programs. However, many interactions may be unavoidable, dose-limiting, or a barrier to THC-based therapy.

Events 48

Events THC Chronic Pain Conditions 48

Cannabis Law Report

SEPTEMBER 9, 2021

MyMD to highlight its development pipeline for MYMD-1, an immunometabolic regulator, and Supera-CBD, a synthetic cannabidiol derivative. Investors may register for the conference at the event website. The live and archived webcast will be available for 90 days after the event. During this presentation, Chris Chapman, M.D.,

Pharmaceutical 74

Pharmaceutical Clinical Trials Chronic Pain Epilepsy 74

Cannabis Law Report

SEPTEMBER 15, 2021

As a result, concentrated amounts of delta-8 THC are typically manufactured from hemp-derived cannabidiol (CBD). . This deceptive marketing of unproven treatments raises significant public health concerns because patients and other consumers may use them instead of approved therapies to treat serious and even fatal diseases.

THC 105

THC Pets Events Hemp 105

Cannabis Law Report

JULY 27, 2021

and its Scientific Advisory Board, the Organization Publishes New Real-World Study on Epilepsy and CBD. The longitudinal study showed that individuals who used artisanal cannabidiol (CBD) products reported better quality of life, lower psychiatric symptom severity and fewer medication-related adverse events compared with those not using CBD.

Data 81

Data Epilepsy Research and Development Clinical Trials 81

The Joint Blog

MARCH 3, 2021

The study found “significant improvements were observed” following the initiation of cannabis therapy in most patients. The study concludes by stating that “The current study revealed the positive effects of MC [medical cannabis] therapy in some patients with FMS [ fibromyalgia syndrome] and resistance to conventional treatment.

Therapy 61

Therapy Hybrid Marijuana Research and Development 61

MMJ Recs

JULY 3, 2024

Cannabidiol (CBD) offers a natural alternative for those seeking relief from the symptoms of anxiety and stress. CBD, derived from the cannabis plant, has garnered attention for its potential therapeutic properties without the psychoactive effects commonly associated with tetrahydrocannabinol (THC). What is CBD?

CBD 52

CBD Research and Development Clinical Trials THC 52

LifeCannMD

MAY 27, 2025

Now, with 1.5mg of a balanced THC:CBD tincture twice daily, he’s giving presentations at work and actually enjoying social events again. After six months of microdosing marijuana (2mg THC + 2mg CBD twice daily), his pain went from an 8/10 to a 3/10, and he’s back to playing golf three times a week.

Microdosing 52

Microdosing Research and Development Sleep Chronic Pain 52

MMJ Recs

DECEMBER 15, 2023

The use of medical marijuana to treat insomnia has gained attention as a potential alternative or complementary therapy. Marijuana contains compounds such as THC and CBD that interact with the endocannabinoid system, which plays a role in regulating sleep. How Can CBD and THC Affect Sleep?

Strains 98

Strains Sleep THC Chronic Pain 98

The Joint Blog

JULY 29, 2021

Cannabidiol, s popularly known as CBD, is a naturally occurring compound accredited to heal pain and several other ailments, including anxiety and depression. Unlike Tetrahydrocannabinol (THC), CBD is not psychoactive. What is CBD oil? CBD is a short name for “cannabinoid.” CBD oil maintains Serotonin Levels.

Oil 55

Oil CBD Sleep Pharmaceutical 55

United Patients Group

DECEMBER 5, 2023

For instance, a study from Washington State University found that inhaling cannabis with low THC and high CBD levels was associated with reduced self-reported anxiety levels. Additionally, a review of existing literature on the subject suggested that CBD may have promising anxiolytic effects.

Research and Development 105

Research and Development Treatment Patients Conditions 105

TheAnswerPage

JANUARY 11, 2022

the components of the cannabis plant (phytocannabinoids, terpenes, and flavonoids) and the health effects of cannabinoid-based therapy in the various patient populations. Who monitors their health and the long-term effects of the marijuana therapy?

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

OCTOBER 19, 2021

will discuss the multiple indications for each of MyMD’s novel drug candidates, MYMD-1 and Supera-CBD. Unlike other therapies, MYMD-1 has been shown to selectively block TNF-? About Supera-CBD. A vast majority of CBD developers are pursuing compounds targeted to CB2 that have minimal CB1 affinity. About MYMD-1.

Pharmaceutical 40

Pharmaceutical Therapy Clinical Trials Chronic Pain 40

WeedAdvisor

MARCH 29, 2019

In a pattern that is all-too-common for the cannabis industry, dispensaries are now plagued by a shortage on CBD oil, according to CBC News. While CBD was already well-known to many medical users, those with only recreational access quickly fell into the hype. Claims About CBD Drive Demand. .

Oil 40

Oil CBD Research and Development Epilepsy 40

United Patients Group

APRIL 28, 2023

Cannabis contains more than a hundred plus compounds known as cannabinoids , the most well-known being tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is the psychoactive compound responsible for producing the “high” due to marijuana use, while CBD is non-psychoactive and has been found to have potential therapeutic benefits.

Marijuana 52

Marijuana Therapy Treatment THC 52

TheAnswerPage

FEBRUARY 23, 2022

Some of these studies have shown positive results, but adverse events were also noted. What are the common adverse events noted in clinical trials examining the efficacy of cannabinoids for ASD? These adverse events were similar the adverse events in the trials examining the efficacy of CBD for the treatment of seizures.

Clinical Trials 40

Clinical Trials Events Therapy Sleep 40

Puff Puff Post

MARCH 19, 2020

In connection with this action, the Company will also suspend sales under its CBD e-commerce platform. The Company will continue to pursue the previously announced sale of the CBD business to The BRN Group Inc. Green Growth Brands creates remarkable experiences in cannabis and CBD. About Green Growth Brands Inc.

Business 84

Business CBD Events Retail 84

The Joint Blog

JANUARY 10, 2022

CBD (cannabidiol) forms part of over 100 chemical components called cannabinoids discovered in the cannabis plant, Cannabis sativa. However, unlike THC, CBD lacks psychoactive effects. However, unlike THC, CBD lacks psychoactive effects. Over the years, consumer interest in CBD’s mental health benefits rose steadily.

CBD 41

CBD Sleep Treatment Epilepsy 41

Cannabis Law Report

JUNE 16, 2021

With increased capacity to screen patients, on a genetic basis, for underlying psychiatric disorders prior to undertaking PAP, Entheon is furthering its commitment toward safety and predictability in psychedelic therapies while aggregating data that can be used to determine which psychedelic molecules are best-suited for a particular patient.”

Research and Development 105

Research and Development Data Conditions Events 105

Cannabis Law Report

SEPTEMBER 22, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced new data demonstrating Supera-CBD’s superior potency over CBD by factor of 8,000 times. A vast majority of CBD developers are pursuing compounds targeted to CB2 that have minimal CB1 affinity.

Pharmaceutical 40

Pharmaceutical Data CBD Clinical Trials 40

Puff Puff Post

MARCH 10, 2020

INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. About INM-755: INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

United Patients Group

JANUARY 10, 2023

When you are dealing with anxiety, it can be very easy to get caught up in your head and ruminate over what might happen in the future or obsess about a past event that made you feel anxious. One of the best ways to calm your anxious brain is to focus on the present moment. reading this article).

Patients 105

Patients Therapy Events Sleep 105

CannaMD

DECEMBER 9, 2020

The authors also list a range of additional conditions for which there are possible benefits of cannabis therapies, including opiate withdraw, dystonia, glaucoma, Alzheimer’s disease, anxiety and depression, anti-tumor effects, inflammatory bowel diseases, Parkinson’s disease, and sleep disorders.

Marijuana 111

Marijuana Research and Development Consumption Vaping 111

Cannabis Law Report

MARCH 19, 2020

Products containing cannabidiol (CBD), ranging from gummies to lotions and oils, continue to grow both in popularity and presence in the marketplace. Food and Drug Administration,” (CBD Report) and provided additional updates on its evaluation of the risks and benefits of CBD products. 18 March 2020. Arnold & Porter.

CBD 45

CBD Research and Development Seed-To-Sale Data 45

The Cannigma

OCTOBER 9, 2021

The common understanding is that every individual has a separate and different reaction to cannabinoid-based therapy, the same is true with how it might influence individual urinary symptoms. The effects of cannabis on micturition are complex with many factors at play.

Cannabinoids 98

Cannabinoids Consumption Patients Cannabis 98

The Joint Blog

MAY 13, 2020

On any given day, we at the Joint Blog get our fair share of questions from our readers about the health benefits of various CBD products on the market. And with everyone trying to exercise at home during self-isolated, we’ve been getting an influx of inquiries about CBD and working out. And What are they used for?

Blood Pressure 52

Blood Pressure Tincture Cannabinoids Topical 52

Cannabis Law Report

DECEMBER 1, 2021

MyMD to highlight its development pipeline for two novel therapeutics: immune regulator MYMD-1 and synthetic cannabidiol derivative Supera-CBD. During the conferences, MyMD executives will discuss the multiple indications being pursued and market opportunities for novel drug candidates MYMD-1 and Supera-CBD. About Supera-CBD.

Pharmaceutical 40

Pharmaceutical Clinical Trials Chronic Pain Therapy 40

The Cannigma

JANUARY 29, 2021

I go into career therapy and I meet all these other women who are in the same boat as I am. Anyway, so I go to this event in 2018 and they’re the white men. JG: I go to this event in Boston and I meet a man who wants to start a cannabis media company and he’s doing a podcast and he hires me as his executive director.

Wellness and Beauty 136

Wellness and Beauty Cannabis History Media 136

Cannabis Law Report

JULY 12, 2019

For both conditions, medical marijuana is not first line treatment and should not replace traditional therapies but should be used in conjunction with them, when recommended by a physician.”. Dr. Levine advised that patients with anxiety disorders should continue to pursue counseling and therapy to manage their illness.

Conditions 40

Conditions Programs Research and Development Marijuana 40